ArticleSisli Etfal Hastanesi tip bulteni2026
Measles Seroprevalence and Associated Factors among Adult Individuals in the City Center of Şanlıurfa Province.
Article in Sisli Etfal Hastanesi tip bulteni, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The aim is to determine measles seroprevalence in adult individuals in Şanlıurfa city center and to evaluate related factors. Methods: The research is of a cross-sectional type. The research was carried out in Şanlıurfa city center between March 2023 and April 2023. The population of the study consisted of individuals over the age of 18 who applied to the Family Health Centers (FHC) in the city center of Şanlıurfa. A 30-cluster sampling method was used to determine the FHCs where the study would be conducted. In this study, the number of people to be included in each cluster was determined as 7, and the total sample size was 210. Thirty FHCs were randomly selected from a total of 80 ASMs in 3 central districts in Şanlıurfa, proportional to the number of units. Blood was drawn from the participants by the researcher. The blood samples were then sent by a private hospital to a private laboratory for testing. Results: A total of 210 adults were included in the study. Fifty-one percent of the participants were women. The measles seropositivity rate of the adults participating in the study was 87.6%, and the measles seronegativity rate was 8.6%. When the participants were examined according to age groups, it was found that the measles seropositivity level was lowest in the 18-21 age group, at 52.63%. In the created logistic regression model, measles seropositivity status in adults: being 33 years or younger reduces it 10 times. Conclusion: This study showed that measles seropositivity in the adult population in Şanlıurfa city center was 87.6%. This suggests the need to reconsider the administration of an extra-dose measles vaccine using the catch-up vaccination method for individuals aged 18-21 and then 22-25, the most susceptible age group in this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.